Table 1.
Basic characteristics of the study population, ages at first experienced symptom of parkinsonism, time from onset of first parkinsonism-symptom to start of first treatment, and imaging techniques recorded
| Age at inclusion to registry (years) | 25th percentile | Median | 75th percentile | Mean (95% CI) |
|---|---|---|---|---|
| All patients (n=1,215) | 69 | 74 | 80 | 74 (73.3-74.3) |
| Females (n=502) | 70 | 75 | 80 | 74 (73.7-75.3) |
| Males (n=715) | 68 | 74 | 79 | 73 (72.7-74.0) |
| Age at data outtake from registry | ||||
| All patients (n=1,217) | 72 | 78 | 83 | 77 (76.4-77.3) |
| Females | 73 | 79 | 83 | 78 (76.9-78.4) |
| Males | 71 | 77 | 82 | 76 (75.6-76.9) |
| Age at onset of first symptom | 61 | 67 | 73 | 66 (65.8-66.9) |
| Females | 62 | 68 | 74 | 67 (66.2-67.9) |
| Males | 60 | 67 | 73 | 66 (65.1-66.6) |
| Time from onset to start of 1st pharmacological treatment (years) | 1.0 | 1.9 | 3.5 | 2.8 (2.6-3.1) |
| Females | 1.0 | 1.8 | 3.4 | 2.8 |
| Males | 0.9 | 2.0 | 3.6 | 2.9 |
|
| ||||
| Imaging (no information for 729 patients) | Total registered (n) | Females (n) (row %/column %) | Males (n) (row %/column %) | |
|
| ||||
| CT scans | 239 | 115 (48/53) | 124 (52/45) | |
| MRIs | 120 | 50 (42/23) | 70 (58/25) | |
| DaT scans | 134 | 52 (39/24) | 82 (61/30) | |
| Total | 483 | 217 | 276 | |
CI: Confidence interval, CT: Computerized tomography, MRI: Magnetic resonance imaging, DaT: Dopamine transporter scans, (No significant differences were identified between groups)